𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lactoferrin in benign hypertrophy and carcinomas of the prostatic gland

✍ Scribed by Barresi, G. ;Tuccari, G.


Publisher
Springer-Verlag
Year
1984
Tongue
English
Weight
634 KB
Volume
403
Category
Article
ISSN
0174-7398

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Immunohistochemical analysis of Ξ²-tubuli
✍ Ranganathan, Sulabha; Salazar, Hernando; Benetatos, Christopher A.; Hudes, Gary πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

## Background: Beta-tubulin, the intracellular target of several antimicrotubule agents, is encoded by at least six genes and exists as multiple isotypes with tissue-specific expression. previous in vitro studies indicated that tubulin isotype composition may affect polymerization properties, dynam

Serum prostatic acid-phosphatase levels
✍ Willet F. Whitmore Jr.; Oscar Bodansky; Morton K. Schwartz; Sai Hou Ying; Emerso πŸ“‚ Article πŸ“… 1956 πŸ› John Wiley and Sons 🌐 English βš– 514 KB

N 1953 Fishman and Lerner reported a tech-I nique for the determination of that portion of the serum acid phosphatasc that originates from the prostate.9 T h e method is based on the observation of Abul-Fad1 and King that L-tartrate inhibits prostatic acid phosphatase. Fishman and co-workers77 8 sub

Detection of sex-region Y (SRY) transcri
✍ Dr. James V. Tricoli; Joyce L. Yao; Sharon A. D'Souza; R. Bruce Bracken πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 532 KB

The human sex-region Y (SRY) gene maps t o Ypl 1.3 and encodes a protein that shares significant sequence homology with a conserved DNA binding motif found in the nonhistone high-mobility group (HMG) proteins. In the mouse, Sry is required for normal testicular development and is expressed in the de

Tissue concentrations of prostate-specif
✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv